U.S. Biotech Stock News

Recent performance and why Vipshop is drawing attention Vipshop Holdings (VIPS) has quietly put together a strong run this year, with the stock up roughly 46% year to date. This performance is prompting investors to revisit its growth story and valuation. See our latest analysis for Vipshop Holdings. That strong year to date share price return of about 46 percent sits alongside a 1 year total shareholder return of roughly 46 percent and a 3 year total shareholder return just above 50 percent,...

In recent months, Northrop Grumman has secured multiple U.S. and allied defense awards, including Space Development Agency Tracking Layer Tranche 3 satellites, a US$264.87 million B-2 rudder contract modification, new Global Hawk and Columbia Launcher Program work, and a US$334.42 million electronic warfare systems award that could expand further if options are exercised. Together with progress in solid rocket motor testing, international partnerships, and Poland’s full operational use of...

Amalgamated Financial (AMAL) has quietly outperformed many regional peers, with the stock up roughly 14% over the past month and nearly 18% in the past 3 months. This performance invites a closer look at what is driving that strength. See our latest analysis for Amalgamated Financial. Despite some short term noise, with a recent 1 day share price return of minus 1.7 percent, Amalgamated Financial's 30 day share price return of 14.4 percent suggests momentum is rebuilding. A 5 year total...

TJX Companies (TJX) has quietly kept rewarding patient shareholders, with the stock up about 11% over the past 3 months and nearly 28% over the past year, handily beating many retail peers. See our latest analysis for TJX Companies. With the share price now around $154.6 and a strong year to date share price return alongside a robust three year total shareholder return, the recent pullback looks more like a pause in a broader uptrend as investors reassess how much of TJX Companies steady...

Synaptics announced that it will showcase its Astra AI-native SoCs, Veros wireless solutions, and multimodal sensing technologies for Edge AI applications at its private suite during CES 2026, held at the Venetian Hotel in Las Vegas. This broad, integrated portfolio across smart home, industrial automation, robotics, and personal devices underscores Synaptics’ push to embed on-device intelligence and connectivity into a wide range of real-world systems. We’ll now examine how Synaptics’ CES...

In recent days, Astronics has attracted attention after receiving a top Momentum Style Score of A and a Zacks Rank of #1 (Strong Buy), alongside upbeat analyst commentary reaffirming confidence in its aerospace and industrial goods operations. This combination of favorable quantitative momentum indicators and bullish analyst sentiment highlights how changing earnings expectations can reshape perceptions of Astronics’ long-term business trajectory. Next, we’ll examine how Astronics’ strong...

Wondering if CenterPoint Energy at around $37.60 is still worth buying after its strong run, or if the easy money has already been made? Let us break it down in plain English before we dive into the valuation models. The stock has cooled off in the short term, slipping about 0.6% over the last week and 5.0% over the last month, yet it still boasts gains of 19.4% year to date and 18.3% over the past year, nearly doubling investors' money with a 98.3% return over five years. Recently,...

If you are wondering whether Aflac at around $110 a share is still a smart buy, or if the big gains are already behind it, you are not alone. That is exactly what this breakdown will tackle. The stock is up 7.8% year to date, 9.8% over the last year, and 182.8% over five years, even though the last month saw a mild dip of 0.6% after a flat 0.3% week. Recently, investors have been responding to Aflac's ongoing share repurchase programs and steady dividend increases, which reinforce its image...

Earlier in December, Travel + Leisure Co. refinanced its 2024 Term Loan B Facility, cutting the interest margin by 50 basis points on US$869 million of borrowings while keeping the December 14, 2029 maturity intact. This lower funding cost, alongside better-than-expected quarterly revenue and operating income and renewed analyst confidence, points to improving financial flexibility for the company. We’ll now examine how the term loan repricing and stronger quarterly performance may influence...

Wondering if Iovance Biotherapeutics is a beaten down biotech bargain or a value trap? You are not alone, and this deep dive will help you decide whether the current price really makes sense. The stock has bounced recently, up 12.7% over the last week and 10.7% over the past month, but that recovery still sits against a tough backdrop of a -68.2% year to date return and -95.0% over five years. Those moves have come as investors refocus on Iovance's pipeline progress and regulatory...

If you have ever wondered whether Commercial Metals is still a smart buy after its big run, you are not alone. This stock has quietly become one of the more interesting value stories in the steel and metals space. Despite a small pullback of about 1.5% over the last week, the share price is up 17.1% in the past month, 41.4% year to date, and an impressive 273.2% over five years, which naturally raises the question of whether the current price fully reflects its fundamentals. Recent attention...

UWM Holdings (UWMC) has quietly slipped this month, adding to a weak past 3 months, even as its revenue and net income are growing. That mismatch is exactly what has value driven investors paying attention. See our latest analysis for UWM Holdings. At around $4.87, UWM Holdings’ recent slide, including a weak 90 day share price return, sits awkwardly against its improving fundamentals. This hints that sentiment has cooled faster than the underlying business, but long term total shareholder...

Zai Lab (ZLAB) just dosed the first participant in its global Phase 1/1b trial for ZL-1503, an internally discovered bispecific antibody for atopic dermatitis, highlighting the company’s innovation pipeline and medium term upside potential. See our latest analysis for Zai Lab. That milestone comes after a choppy stretch for investors, with the 90 day share price return down 45.58 percent and the 1 year total shareholder return at negative 32.48 percent, suggesting sentiment may be cautious...

Wondering if FTI Consulting at around $176 a share is quietly turning into a value opportunity, or if the easy money has already been made? Here is a closer look at what the current price is really implying. The stock has bounced recently, up 3.4% over the last week and 7.6% over the past month, even though it is still down 7.0% year to date and 9.6% over the last year, after gains of 12.5% over three years and 59.0% over five years. That mixed performance comes against a backdrop of FTI...

Carnival Corporation (CCL) capped FY 2025 with fourth quarter revenue of about $6.3 billion and basic EPS of $0.32, while trailing 12 month revenue reached roughly $26.6 billion alongside EPS of $2.10. The company has seen revenue move from around $24.5 billion to $26.6 billion over the last six reported trailing 12 month snapshots, with EPS climbing from $1.24 to $2.10, setting up a picture of firmer profitability and healthier margins that investors will be keen to parse in the latest...

If you are wondering whether BILL Holdings is a beaten down opportunity or a value trap at around $55 a share, you are not alone. This piece will unpack what the current price is really telling us. Despite a tough longer term picture with the stock down 37.5% over the last year and 62.3% over five years, the recent momentum has flipped. Shares are up 2.6% over the past week and 16.2% over the last month, even though the year to date return is still a 33.4% decline. That swing in sentiment...

Bank of New York Mellon (BK) is back on traders dashboards ahead of its upcoming fourth quarter report, as the market weighs upbeat profit expectations against the bank ongoing push into AI driven operations. See our latest analysis for Bank of New York Mellon. The stock has quietly built strong momentum, with an 8.84% 1 month share price return contributing to a 49.64% year to date share price gain and a 5 year total shareholder return of 226.07%. This suggests investors are steadily...

Intuitive Surgical (ISRG) just delivered a clean combination of earnings upside, fresh FDA clearances for its da Vinci Single Port system, and a shift to direct distribution in Southern Europe, all pointing toward a bigger, higher margin opportunity set. See our latest analysis for Intuitive Surgical. Those beats and new clearances have helped the stock regain momentum, with a 90 day share price return of 28.78% and a five year total shareholder return of 112.81%. This suggests investors...

If you are wondering whether FormFactor is still attractive after such a strong run, or if the easy money has already been made, you are not alone. The stock has climbed 2.8% over the past week, 15.3% in the last month, and is now up 28.8% year to date and 32.9% over the past year, adding to an impressive 165.6% gain over three years. Recent coverage has highlighted how demand for advanced semiconductor testing solutions is benefiting equipment providers like FormFactor, as chipmakers keep...

Ennis (EBF) has just posted its Q3 2026 numbers, logging about $100.2 million in revenue and net income of roughly $10.8 million, which translated into EPS of $0.43 for the quarter. The company has seen quarterly revenue hover in a tight band between roughly $92.7 million and $100.2 million over the past six reported periods, while EPS has moved between about $0.35 and $0.51, giving investors a steady read on top line and per share performance. With net profit margins running close to 11%...

Fresh commentary on Lithia Motors (LAD) is putting a spotlight on its weaker same store sales and high leverage, and the stock is reacting as investors reassess how durable its growth story really is. See our latest analysis for Lithia Motors. The stock has enjoyed a solid 30 day share price return of 13.69 percent to about $343.89. However, that sits against a slightly negative year to date share price return and a modestly negative 1 year total shareholder return. This suggests momentum is...

The California Public Utilities Commission’s decision to let Sempra (SRE) keep roughly 10% returns on equity at its California utilities in 2026 gives investors clearer visibility on earnings, even as consumer advocates push back. See our latest analysis for Sempra. Even with the CPUC decision shoring up earnings visibility, Sempra’s recent share price return has cooled, with a roughly 6% one month pullback after a stronger 90 day gain. Its five year total shareholder return above 60% still...

Westinghouse Air Brake Technologies (WAB) just posted third quarter results that topped earnings and revenue expectations, while closing its cash acquisition of Frauscher Sensor Technology Group, a deal that is expected to meaningfully lift future sales. See our latest analysis for Westinghouse Air Brake Technologies. Those upbeat results and the Frauscher deal come on top of easing bearish sentiment, with short interest drifting lower and the stock showing solid momentum, including a roughly...

G-III Apparel Group (GIII) just delivered a mixed update, with softer third quarter sales and earnings but a higher full year profit outlook, and paired it with a new quarterly dividend program. See our latest analysis for G-III Apparel Group. The latest pullback, including a 1 day share price return of negative 4.21 percent and weaker quarterly numbers, comes against a backdrop of solid momentum. The 3 month share price return stands at 13.76 percent and the 3 year total shareholder return...